NCT07790315

Brief Summary

Clear aligner therapy is an esthetic orthodontic treatment modality that uses removable thermoplastic trays to correct dental alignment. Different thermoplastic materials, including thermoplastic polyurethane (TPU) and polyethylene terephthalate glycol (PETG), may differ in flexibility and mechanical behavior. These material differences may influence patient-reported outcomes such as pain, mucosal ulceration, tooth sensitivity, tooth mobility, and material-related allergic symptoms. This randomized, double-blind, parallel-group clinical trial will compare patient-reported outcomes in patients treated with clear aligners fabricated from TPU versus PETG. Participants requiring non-extraction clear aligner therapy for mild to moderate crowding will be randomly allocated in a 1:1 ratio to receive aligners fabricated from either PETG or TPU. Outcomes will be recorded at five predefined time points after aligner assignment and wear: T0 before aligner wear, T1 immediately after aligner insertion/wear, T2 at day 1, T3 at day 3, and T4 at day 7.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Aug 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
Aug 2026Dec 2026

First Submitted

Initial submission to the registry

August 7, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

August 10, 2026

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 27, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2026

Expected
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

August 27, 2026

Status Verified

August 1, 2026

Enrollment Period

3 months

First QC Date

August 7, 2026

Last Update Submit

August 24, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain intensity during clear aligner therapy

    Pain experienced by the participant will be recorded using a visual analog scale (VAS) from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain.

    During each of the first four aligner cycles: before aligner insertion; immediately after aligner insertion; and 1 day, 3 days, and 7 days after aligner insertion.

Secondary Outcomes (4)

  • Mucosal ulceration or soft-tissue trauma related to aligner wear

    During each of the first four aligner cycles: before aligner insertion; immediately after aligner insertion; and 1 day, 3 days, and 7 days after aligner insertion.

  • Tooth sensitivity

    During each of the first four aligner cycles: before aligner insertion; immediately after aligner insertion; and 1 day, 3 days, and 7 days after aligner insertion.

  • Tooth mobility

    During each of the first four aligner cycles: before aligner insertion; immediately after aligner insertion; and 1 day, 3 days, and 7 days after aligner insertion.

  • Allergic symptoms or material-related adverse reaction

    During each of the first four aligner cycles: before aligner insertion; immediately after aligner insertion; and 1 day, 3 days, and 7 days after aligner insertion.

Study Arms (2)

Experimental Arm A: PETG clear aligners

EXPERIMENTAL

Participants will receive clear aligners fabricated from polyethylene terephthalate glycol (PETG). Aligners will be planned for routine orthodontic alignment, including proclination, expansion, or interdental enamel reduction when clinically indicated. Each aligner will be worn for 10 days.

Device: Device / orthodontic clear aligner material

Experimental Arm B: TPU clear aligners

EXPERIMENTAL

Participants will receive clear aligners fabricated from thermoplastic polyurethane (TPU). Aligners will be planned for routine orthodontic alignment, including proclination, expansion, or interdental enamel reduction when clinically indicated. Each aligner will be worn for 10 days.

Device: Device / orthodontic clear aligner material

Interventions

Clear aligners fabricated from polyethylene terephthalate glycol (PETG) thermoplastic material. Aligners will be worn for 10 days before progression to the next aligner.

Also known as: Clear aligner fabricated from PETG thermoplastic material
Experimental Arm A: PETG clear aligners

Eligibility Criteria

Age15 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patient aged between 15 and 30 years.
  • Permanent dentition, with all permanent teeth from first molar to first molar present.
  • Mild to moderate crowding less than 8 mm.
  • Non-extraction orthodontic treatment plan.
  • Ability and willingness to wear aligners for the required time.
  • Willingness to attend regular visits during orthodontic treatment.

You may not qualify if:

  • Syndromic patients.
  • Known allergy to thermoplastic materials.
  • Patients with systemic diseases that may affect orthodontic treatment or outcome assessment.
  • Patients requiring extraction as part of orthodontic treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CMH Lahore Medical college and institue of dentistry

Lahore, Punjab Province, 54000, Pakistan

Location

Study Officials

  • HARIS KHAN, BDS,FCPS

    CMH Lahore medical college and IOD

    PRINCIPAL INVESTIGATOR

Central Study Contacts

HARIS KHAN, BDS, FCPS

CONTACT

Hani Javed, BDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Double masking: participant and outcome assessor
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 7, 2026

First Posted

August 27, 2026

Study Start

August 10, 2026

Primary Completion (Estimated)

November 15, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

August 27, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations